Work

MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy

Year: 2015

Type: article

Abstract: Meeting abstracts Adoptive immunotherapy with genetically modified T cells holds promise in improving outcomes for cancer patients. While a broad array of genetic modification strategies are being explored, few allow for the specific manipulation of adoptively transferred T cells in vivo . One

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-3-s2-p118

Authors: Melinda Mata, Claudia Gerken, David M Spencer, Stephen Gottschalk

Institutions: Baylor College of Medicine, Bellicum Pharmaceuticals (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490